Cornea and Glaucoma treatment news

The synthetic cornea from Israel’s CorNeat is beginning human trials, as reported here in July. This has become vital due to shortage of human corneas during Covid-19. CorNeat will soon begin trials of its EverPatch for Glaucoma surgery and is developing the eShunt to reduce eye pressure.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *